Viral heparin-binding complement inhibitors - A recurring theme

Advances in Experimental Medicine and Biology

Volumn 598, Issue , 2007, Pages 105-125

  Blom, Anna M ^a   Mark, Linda ^a   Spiller, O Brad ^b  

^a LUND UNIVERSITY   (Sweden)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; HEPARIN; PROTEIN C; PROTEIN INHIBITOR; PROTEIN RCA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; BINDING AFFINITY; CONFERENCE PAPER; ENZYME ACTIVATION; GENE CONTROL; GENE INSERTION; GENE MUTATION; GENETIC CONSERVATION; HERPES VIRUS; HOST RESISTANCE; INNATE IMMUNITY; NONHUMAN; ORTHOPOXVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY;

EID: 84934438604     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-71767-8_9     Document Type: Conference Paper

References (99)

1. Akula, S.M., Pramod, N.P., Wang, F.Z., and Chandran, B. (2001) Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties. Virology 284, 235-49.
2. Albrecht, J.C., Nicholas, J., Biller, D., Cameron, K.R., Biesinger, B., Newman, C., Wittmann, S., Craxton, M.A., Coleman, H., and Fleckenstein, B. (1992) Primary structure of the herpesvirus saimiri genome. J Virol 66, 5047-58.
3. Arnold, J.N., Dwek, R.A., Rudd, P.M., and Sim, R.B. (2006) Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol Lett 106, 103-10.
4. Avrameas, S. (1991) Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today 12, 154-9.
5. Bajtay, Z., Speth, C., Erdei, A., and Dierich, M.P. (2004) Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18) J Immunol 173, 4775-8.
6. Banki, Z., Stoiber, H., and Dierich, M.P. (2005) HIV and human complement: inefficient virolysis and effective adherence. Immunol Lett 97, 209-14.
7. Blackmore, T.K., Hellwage, J., Sadlon, T.A., Higgs, N., Zipfel, P.F., Ward, H.M., and Gordon, D.L. (1998) Identification of the second heparin-binding domain in human complement factor H. J Immunol 160, 3342-8.
8. Blom, A.M., Kask, L., and Dahlback, B. (2001) Structural requirements for the complement regulatory activities of C4BP. J Biol Chem 276, 27136-44.
9. Caprioli, J., Bettinaglio, P., Zipfel, P.F., Amadei, B., Daina, E., Gamba, S., Skerka, C., Marziliano, N., Remuzzi, G., and Noris, M. (2001) The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 12, 297-307. Notes: CORPORATE NAME: Itaslian Registry of Familial and Recurrent HUS/TTP
10. Cesarman, E., Chang, Y., Moore, P.S., Said, J.W., and Knowles, D.M. (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332, 1186-91.
11. Chen, Y.T., Wang, Y.H., Cheng, Y.Y., and Hung, S.L. (2003) Direct binding of herpes simplex virus type 1 virions to complement C3. Viral Immunol 16, 347-55.
12. Daniels, C.A., Borsos, T., Rapp, H.J., Snyderman, R., and Notkins, A.L. (1970) Neutralization of sensitized virus by purified components of complement. Proc Natl Acad Sci U S A 65, 528-35.
13. Eizuru, Y., Ueno, I., and Minamishima, Y. (1988) Evaluation of immunoglobulin G preparations for anti-cytomegalovirus antibodies with reference to neutralizing antibody in the presence of complement. J Clin Microbiol 26, 1881-3.
14. Endo, Y., Takahashi, M., and Fujita, T. (2006) Lectin complement system and pattern recognition. Immunobiology 211, 283-93.
15. Fodor, W.L., Rollins, S.A., Bianco-Caron, S., Rother, R.P., Guilmette, E.R., Burton, W.V., Albrecht, J.C., Fleckenstein, B., and Squinto, S.P. (1995) The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J Virol 69, 3889-92.
16. Friedman, H.M., Cohen, G.H., Eisenberg, R.J., Seidel, C.A., and Cines, D.B. (1984) Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 309, 633-5.
17. Friedman, H.M., Glorioso, J.C., Cohen, G.H., Hastings, J.C., Harris, S.L., and Eisenberg, R.J. (1986) Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates. J Virol 60, 470-5.
18. Friedman, H.M., Wang, L., Fishman, N.O., Lambris, J.D., Eisenberg, R.J., Cohen, G.H., and Lubinski, J. (1996) Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. J Virol 70, 4253-60.
19. Fries, L.F., Friedman, H.M., Cohen, G.H., Eisenberg, R.J., Hammer, C.H., and Frank, M.M. (1986) Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. J Immunol 137, 1636-41.
20. Galili, U., Mandrell, R.E., Hamadeh, R.M., Shohet, S.B., and Griffiss, J.M. (1988a) Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 56, 1730-7.
21. Galili, U., Shohet, S.B., Kobrin, E., Stults, C.L., and Macher, B.A. (1988b) Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 263, 17755-62.
22. Ganesh, V.K., Smith, S.A., Kotwal, G.J., and Murthy, K.H. (2004) Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation. Proc Natl Acad Sci U S A 101, 8924-9.
23. Gerber, S.I., Belval, B.J., and Herold, B.C. (1995) Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism. Virology 214, 29-39.
24. Ghebremariam, Y.T., Odunuga, O.O., Janse, K., and Kotwal, G.J. (2005) Humanized Recombinant Vaccinia Virus Complement Control Protein (hrVCP) with Three Amino Acid Changes, H98Y, E102K, and E120K Creating an Additional Putative Heparin Binding Site, Is 100-fold More Active Than rVCP in Blocking Both Classical and Alternative Complement Pathways. Ann N Y Acad Sci 1056, 113-22.
25. Goodfellow, I.G., Evans, D.J., Blom, A.M., Kerrigan, D., Miners, J.S., Morgan, B.P., and Spiller, O.B. (2005) Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors. J Virol 79, 12016-24.
26. Green, T.D., Montefiori, D.C., and Ross, T.M. (2003) Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. J Virol 77, 2046-55.
27. Harris, C.L., Spiller, O.B., and Morgan, B.P. (2000) Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities. Immunology 100, 462-70.
28. Harris, S.L., Frank, I., Yee, A., Cohen, G.H., Eisenberg, R.J., and Friedman, H.M. (1990) Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J Infect Dis 162, 331-7.
29. Herold, B.C., Visalli, R.J., Susmarski, N., Brandt, C.R., and Spear, P.G. (1994) Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J Gen Virol 75 ( Pt 6), 1211-22.
30. Herold, B.C., WuDunn, D., Soltys, N., and Spear, P.G. (1991) Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol 65, 1090-8.
31. Herzenberg, L.A. and Kantor, A.B. (1993) B-cell lineages exist in the mouse. Immunol Today 14, 79-83; discussion 88-90.
32. Hileman, R.E., Fromm, J.R., Weiler, J.M., and Linhardt, R.J. (1998) Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 20, 156-67.
33. Homa, F.L., Purifoy, D.J., Glorioso, J.C., and Levine, M. (1986) Molecular basis of the glycoprotein C-negative phenotypes of herpes simplex virus type 1 mutants selected with a virus-neutralizing monoclonal antibody. J Virol 58, 281-9.
34. Hook, L.M., Lubinski, J.M., Jiang, M., Pangburn, M.K., and Friedman, H.M. (2006) Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody. J Virol 80, 4038-46.
35. Huemer, H.P., Broker, M., Larcher, C., Lambris, J.D., and Dierich, M.P. (1989) The central segment of herpes simplex virus type 1 glycoprotein C (gC) is not involved in C3b binding: demonstration by using monoclonal antibodies and recombinant gC expressed in Escherichia coli. J Gen Virol 70 ( Pt 6), 1571-8.
36. Huemer, H.P., Larcher, C., and Coe, N.E. (1992) Pseudorabies virus glycoprotein III derived from virions and infected cells binds to the third component of complement. Virus Res 23, 271-80.
37. Huemer, H.P., Nowotny, N., Crabb, B.S., Meyer, H., and Hubert, P.H. (1995) gp13 (EHV-gC): a complement receptor induced by equine herpesviruses. Virus Res 37, 113-26.
38. Huemer, H.P., Wang, Y., Garred, P., Koistinen, V., and Oppermann, S. (1993) Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein. Immunology 79, 639-47.
39. Huemer, H.P., Wechselberger, C., Bennett, A.M., Falke, D., and Harrington, L. (2003) Cloning and expression of the complement receptor glycoprotein C from Herpesvirus simiae (herpes B virus): protection from complement-mediated cell lysis. J Gen Virol 84, 1091-100.
40. Hung, S.L., Peng, C., Kostavasili, I., Friedman, H.M., Lambris, J.D., Eisenberg, R.J., and Cohen, G.H. (1994) The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway. Virology 203, 299-312.
41. Hung, S.L., Srinivasan, S., Friedman, H.M., Eisenberg, R.J., and Cohen, G.H. (1992) Structural basis of C3b binding by glycoprotein C of herpes simplex virus. J Virol 66, 4013-27.
42. Isaacs, S.N., Kotwal, G.J., and Moss, B. (1992) Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc Natl Acad Sci U S A 89, 628-32.
43. Kapadia, S.B., Levine, B., Speck, S.H., and Virgin, H.W. 4th (2002) Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection. Immunity 17, 143-55.
44. Kapadia, S.B., Molina, H., van Berkel, V., Speck, S.H., and Virgin, H.W. 4th (1999) Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J Virol 73, 7658-70.
45. Kostavasili, I., Sahu, A., Friedman, H.M., Eisenberg, R.J., Cohen, G.H., and Lambris, J.D. (1997) Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J Immunol 158, 1763-71.
46. Kotwal, G.J., Isaacs, S.N., McKenzie, R., Frank, M.M., and Moss, B. (1990) Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250, 827-30.
47. Kotwal, G.J. and Moss, B. (1988) Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335, 176-8.
48. Lewis, R.B., Matzke, D.S., Albrecht, T.B., and Pollard, R.B. (1986) Assessment of the presence of cytomegalovirus-neutralizing antibody by a plaque-reduction assay. Rev Infect Dis 8 Suppl 4, S434-8.
49. Linhardt, R.J. (2003) 2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity. J Med Chem 46, 2551-64.
50. Liszewski, M.K., Leung, M.K., Hauhart, R., Buller, R.M., Bertram, P., Wang, X., Rosengard, A.M., Kotwal, G.J., and Atkinson, J.P. (2006) Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. J Immunol 176, 3725-34.
51. Lubinski, J., Wang, L., Mastellos, D., Sahu, A., Lambris, J.D., and Friedman, H.M. (1999) In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J Exp Med 190, 1637-46.
52. Lubinski, J.M., Wang, L., Soulika, A.M., Burger, R., Wetsel, R.A., Colten, H., Cohen, G.H., Eisenberg, R.J., Lambris, J.D., and Friedman, H.M. (1998) Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo. J Virol 72, 8257-63.
53. Maeda, K., Hayashi, S., Tanioka, Y., Matsumoto, Y., and Otsuka, H. (2002) Pseudorabies virus (PRV) is protected from complement attack by cellular factors and glycoprotein C (gC) Virus Res 84, 79-87.
54. Mardberg, K., Trybala, E., Glorioso, J.C., and Bergstrom, T. (2001) Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C. J Gen Virol 82, 1941-50.
55. Mark, L., Lee, W.H., Spiller, O.B., Villoutreix, B.O., and Blom, A.M. (2006) The Kaposi's sarcoma-associated herpesvirus complement control protein (KCP) binds to heparin and cell surfaces via positively charged amino acids in CCP1-2. Mol Immunol 43, 1665-75.
56. McGrath, Y., Wilkinson, G.W., Spiller, O.B., and Morgan, B.P. (1999) Development of adenovirus vectors encoding rat complement regulators for use in therapy in rodent models of inflammatory diseases. J Immunol 163, 6834-40.
57. McKenzie, R., Kotwal, G.J., Moss, B., Hammer, C.H., and Frank, M.M. (1992) Regulation of complement activity by vaccinia virus complement-control protein. J Infect Dis 166, 1245-50.
58. McNearney, T.A., Odell, C., Holers, V.M., Spear, P.G., and Atkinson, J.P. (1987) Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity. J Exp Med 166, 1525-35.
59. Morgan, B.P., Marchbank, K.J., Longhi, M.P., Harris, C.L., and Gallimore, A.M. (2005) Complement: central to innate immunity and bridging to adaptive responses. Immunol Lett 97, 171-9.
60. Mullick, J., Bernet, J., Singh, A.K., Lambris, J.D., and Sahu, A. (2003). Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins. J Virol 77, 3878-81.
61. Mullick, J., Singh, A.K., Panse, Y., Yadav, V., Bernet, J., and Sahu, A. (2005). Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J Virol 79, 5850-6.
62. Murthy, K.H., Smith, S.A., Ganesh, V.K., Judge, K.W., Mullin, N., Barlow, P.N., Ogata, C.M., and Kotwal, G.J. (2001) Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans. Cell 104, 301-11.
63. Olofsson, S., Bolmstedt, A., Biller, M., Mardberg, K., Leckner, J., Malmstrom, B.G., Trybala, E., and Bergstrom, T. (1999) The role of a single N-linked glycosylation site for a functional epitope of herpes simplex virus type 1 envelope glycoprotein gC. Glycobiology 9, 73-81.
64. Oppermann, M., Manuelian, T., Jozsi, M., Brandt, E., Jokiranta, T.S., Heinen, S., Meri, S., Skerka, C., Gotze, O., and Zipfel, P.F. (2006) The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein. Clin Exp Immunol 144, 342-52.
65. Perez-Caballero, D., Gonzalez-Rubio, C., Gallardo, M.E., Vera, M., Lopez-Trascasa, M., Rodriguez de Cordoba, S., and Sanchez-Corral, P. (2001) Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet 68, 478-84.
66. Petitou, M., Casu, B., and Lindahl, U. (2003) 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site. Biochimie 85, 83-9.
67. Pinter, C., Beltrami, S., Stoiber, H., Negri, D.R., Titti, F., and Clivio, A. (2000) Interference with complement regulatory molecules as a possible therapeutic strategy in HIV infection. Expert Opin Investig Drugs 9, 199-205.
68. Richards, A., Buddles, M.R., Donne, R.L., Kaplan, B.S., Kirk, E., Venning, M.C., Tielemans, C.L., Goodship, J.A., and Goodship, T.H. (2001) Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am J Hum Genet 68, 485-90.
69. Rioux, P. (2001) TP-10 (AVANT Immunotherapeutics) Curr Opin Investig Drugs 2, 364-71.
70. Rooijakkers, S.H. and van Strijp, J.A. (2007) Bacterial complement evasion. Mol Immunol 44, 23-32.
71. Rosengard, A.M., Liu, Y., Nie, Z., and Jimenez, R. (2002) Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc Natl Acad Sci U S A 99, 8808-13.
72. Rundell, B.B. and Betts, R.F. (1982) Neutralization and sensitization of cytomegalovirus by IgG antibody, anti-IgG antibody, and complement. J Med Virol 10, 109-18.
73. Russo, J.J., Bohenzky, R.A., Chien, M.C., Chen, J., Yan, M., Maddalena, D., Parry, J.P., Peruzzi, D., Edelman, I.S., Chang, Y., and Moore, P.S. (1996) Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) Proc Natl Acad Sci U S A 93, 14862-7.
74. Saevarsdottir, S., Vikingsdottir, T., and Valdimarsson, H. (2004) The potential role of mannan-binding lectin in the clearance of self-components including immune complexes. Scand J Immunol 60, 23-9.
75. Sahu, A., Isaacs, S.N., Soulika, A.M., and Lambris, J.D. (1998) Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. J Immunol 160, 5596-604.
76. Seidel-Dugan, C., Ponce de Leon, M., Friedman, H.M., Eisenberg, R.J., and Cohen, G.H. (1990) Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein C. J Virol 64, 1897-906.
77. Seidel-Dugan, C., Ponce de Leon, M., Friedman, H.M., Fries, L.F., Frank, M.M., Cohen, G.H., and Eisenberg, R.J. (1988) C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2. J Virol 62, 4027-36.
78. Sharma, A.K. and Pangburn, M.K. (1996) Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc Natl Acad Sci U S A 93, 10996-1001.
79. Singh, A.K., Mullick, J., Bernet, J., and Sahu, A. (2006) Functional characterization of the complement control protein homolog of herpesvirus saimiri: ARG-118 is critical for factor I cofactor activities. J Biol Chem 281, 23119-28.
80. Smith, S.A., Mullin, N.P., Parkinson, J., Shchelkunov, S.N., Totmenin, A.V., Loparev, V.N., Srisatjaluk, R., Reynolds, D.N., Keeling, K.L., Justus, D.E., Barlow, P.N., and Kotwal, G.J. (2000) Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense. J Virol 74, 5659-66.
81. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M.F., Clauvel, J.P., Raphael, M., and Degos, L. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276-80.
82. Spear, G.T., Lurain, N.S., Parker, C.J., Ghassemi, M., Payne, G.H., and Saifuddin, M. (1995) Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV) J Immunol 155, 4376-81.
83. Spiller, O.B., Blackbourn, D.J., Mark, L., Proctor, D.G., and Blom, A.M. (2003) Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus. J Biol Chem 278, 9283-9.
84. Spiller, O.B., Hanna, S.M., Devine, D.V., and Tufaro, F. (1997) Neutralization of cytomegalovirus virions: the role of complement. J Infect Dis 176, 339-47.
85. Spiller, O.B., Mark, L., Blue, C.E., Proctor, D.G., Aitken, J.A., Blom, A.M., and Blackbourn, D.J. (2006) Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding. J Virol 80, 4068-78.
86. Spiller, O.B. and Morgan, B.P. (1998) Antibody-independent activation of the classical complement pathway by cytomegalovirus-infected fibroblasts. J Infect Dis 178, 1597-603.
87. Spiller, O.B., Morgan, B.P., Tufaro, F., and Devine, D.V. (1996) Altered expression of host-encoded complement regulators on human cytomegalovirus- infected cells. Eur J Immunol 26, 1532-8.
88. Spiller, O.B., Robinson, M., O'Donnell, E., Milligan, S., Morgan, B.P., Davison, A.J., and Blackbourn, D.J. (2003) Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein. J Virol 77, 592-9.
89. Tal-Singer, R., Peng, C., Ponce De Leon, M., Abrams, W.R., Banfield, B.W., Tufaro, F., Cohen, G.H., and Eisenberg, R.J. (1995) Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol 69, 4471-83.
90. Tal-Singer, R., Seidel-Dugan, C., Fries, L., Huemer, H.P., Eisenberg, R.J., Cohen, G.H., and Friedman, H.M. (1991) Herpes simplex virus glycoprotein C is a receptor for complement component iC3b. J Infect Dis 164, 750-3
91. Thieblemont, N., Haeffner-Cavaillon, N., Ledur, A., L'Age-Stehr, J., Ziegler-Heitbrock, H.W., and Kazatchkine, M.D. (1993) CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4. Clin Exp Immunol 92, 106-13.
92. Trybala, E., Bergstrom, T., Svennerholm, B., Jeansson, S., Glorioso, J.C., and Olofsson, S. (1994) Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate. J Gen Virol 75 ( Pt 4), 743-52.
93. Vanderplasschen, A., Mathew, E., Hollinshead, M., Sim, R.B., and Smith, G.L. (1998) Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci U S A 95, 7544-9.
94. Walport, M.J. (2001) Complement. First of two parts. N Engl J Med 344, 1058-66.
95. Wang, F.Z., Akula, S.M., Pramod, N.P., Zeng, L., and Chandran, B. (2001) Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J Virol 75, 7517-27.
96. Watanabe, I., Ross, T.M., Tamura, S., Ichinohe, T., Ito, S., Takahashi, H., Sawa, H., Chiba, J., Kurata, T., Sata, T., and Hasegawa, H. (2003) Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin. Vaccine 21, 4532-8.
97. Wu, C.T., Levine, M., Homa, F., Highlander, S.L., and Glorioso, J.C. (1990) Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants. J Virol 64, 856-63.
98. Yu, H., Munoz, E.M., Edens, R.E., and Linhardt, R.J. (2005) Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance. Biochim Biophys Acta 1726, 168-76.
99. Zipfel, P.F. (2001) Complement factor H: physiology and pathophysiology. Semin Thromb Hemost 27, 191-9.